Developer docs
API playgroundTry for free, no card

Search company profiles

Hameln Pharma Ltd

Full company profile

uuid00sjjn2

Namestring
Hameln Pharma Ltd
Legal namestring
hameln pharma gmbh
Websiteurl
hameln.co.uk
Company typeenum
Private
Founded yearint
1890
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGloucester, United Kingdom
HQ citystring
Gloucester
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic injectable medicines, pharmaceutical manufacturing, hospital pharmaceutical supplies, opioid injectable products, critical care pharmaceuticals
Industry3 codes
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYHLAIAAAN
Pain Management & Anesthesiology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHSABALAG
Injectables & Specialty Medication Support (e.g., insulin, biologics)
Home & Personal Services/Elder Care & In-Home Care Services/Medication Management & In-Home Pharmacy Support
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Generic Injectable Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Generic Injectable Medicines Sales
TypeOne Time License
Description

Sale of generic injectable pharmaceutical products including analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products to hospitals, pharmacies, and healthcare facilities globally.

hameln-pharma.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Hameln Pharma Ltd is a fourth-generation owner-managed pharmaceutical group that develops, licenses, manufactures, and markets generic injectable medicines, including analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products. The company delivers more than 140 million doses per year across 65+ active ingredients to hospitals, pharmacies, outpatient surgery centres, medical practices, and palliative care centres in more than 45 countries through nine wholly owned subsidiary companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 140 million doses delivered to customers in 2024
+2 more records
Product overview1 text field

Hameln Pharma Ltd operates as a single unified portfolio of generic injectable medicines with supporting product lines. The core offering comprises a broad portfolio of generic injectable medicines spanning analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products. This portfolio is supported by three named product/service offerings: Ready-to-Use Products with Integrated Syringe Label® (pre-filled syringes with integrated labeling for clinical efficiency), Intelligent Packaging Design (proprietary packaging solutions for safety and usability), and Robust Supply Chain (logistics services for global distribution). The company delivers more than 140 million doses annually across 65+ active ingredients in 45+ countries, positioning the injectable medicines portfolio as the central platform with specialized packaging and supply chain services as complementary capabilities.

Product and service3 records
1Generic Injectable Medicines Portfolio
CategoryGeneric Injectable Pharmaceuticals
Description

Broad range of generic injectable medicines covering analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products used in hospitals, pharmacies, outpatient surgery centres, and palliative care settings.

2Ready-to-Use Products with Integrated Syringe Label
CategoryPharmaceutical Packaging Innovation
Description

Pre-filled syringes and ready-to-administer injectable products featuring an integrated syringe label designed to improve preparation efficiency and reduce medication errors in clinical settings.

3Intelligent Packaging Design
CategoryPharmaceutical Packaging Innovation
Description

Proprietary packaging solutions designed to enhance safety, usability, and efficiency in the handling and administration of injectable medicines.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Sun Pharmaceutical Industries
TypeBroad incumbent
Description

Indian-headquartered global generics manufacturer with sterile injectables in its portfolio. Less concentrated in injectables than Hameln, but competes for hospital tenders in overlapping markets.

TypeDirect peer
Description

Indian-headquartered generic pharmaceutical manufacturer with a growing sterile injectables business supplying regulated markets including Europe. Comparable to Hameln in targeting generic injectable tenders and hospital accounts.

TypeBroad incumbent
Description

Global generics and specialty company formed from Mylan and Upjohn, with injectable products serving hospital and surgical markets. Overlaps with Hameln in hospital-channel generic injectables but operates with much greater therapeutic and geographic breadth.

4Sandoz
TypeBroad incumbent
Description

Global generics leader and Novartis spin-off with a sizable sterile injectable franchise across antibiotics, oncology, and hospital injectables. Overlaps with Hameln in generic injectables for hospitals but operates at significantly larger scale and breadth.

TypeDirect peer
Description

German-headquartered global supplier of generic injectable medicines, IV drugs, and clinical nutrition to hospitals. Directly comparable to Hameln in therapeutic focus, customer base (hospitals), and reliance on tender-based generic injectable distribution.

TypeDirect peer
Description

German medical and pharmaceutical company with a major sterile injectable and infusion solutions business serving hospitals globally. Closely matches Hameln on geography of origin, injectable expertise, and hospital-channel distribution model.

TypeBroad incumbent
Description

One of the world's largest generic drug manufacturers with a meaningful injectable portfolio serving hospitals. Competes with Hameln in tender-based generic injectable markets but is far broader in scope (oral solids, biosimilars, APIs).

TypeDirect peer
Description

Specialty generic injectable manufacturer with strong hospital channel presence across Europe, MENA, and the US. Comparable to Hameln in portfolio breadth (anesthetics, analgesics, critical care injectables) and contract/tender-driven sales.

TypeDirect peer
Description

Indian generics company with a focused sterile injectables portfolio (anesthetics, oncology injectables) sold into European and emerging markets. Comparable to Hameln in therapeutic mix and regulatory-driven hospital sales.

TypeBroad incumbent
Description

Pfizer's injectables business, built on the Hospira acquisition, supplies a broad hospital injectable portfolio including analgesics and anesthesia adjacents. Competes with Hameln in the same hospital channels but at much larger scale and broader therapeutic depth.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hameln Pharma Ltd

Generic Injectable Pharmaceuticalshameln.co.uk

Hameln Pharma Ltd firmographics

Firmographics
Name
Hameln Pharma Ltd
Legal name
hameln pharma gmbh
Website
https://hameln.co.uk
Company type
Private
Founded year
1890
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Where Hameln Pharma Ltd is headquartered

Location

Headquarters

HQ city
Gloucester
HQ country
United Kingdom
HQ region
Europe

Offices9 records

Markets served

Hameln Pharma Ltd business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Generic Injectable Medicines Sales: Sale of generic injectable pharmaceutical products including analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products to hospitals, pharmacies, and healthcare facilities globally.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Hameln Pharma Ltd product offering

Product offering

Core offering

Hameln Pharma Ltd is a fourth-generation owner-managed pharmaceutical group that develops, licenses, manufactures, and markets generic injectable medicines, including analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products. The company delivers more than 140 million doses per year across 65+ active ingredients to hospitals, pharmacies, outpatient surgery centres, medical practices, and palliative care centres in more than 45 countries through nine wholly owned subsidiary companies.

Product overview

Hameln Pharma Ltd operates as a single unified portfolio of generic injectable medicines with supporting product lines. The core offering comprises a broad portfolio of generic injectable medicines spanning analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products. This portfolio is supported by three named product/service offerings: Ready-to-Use Products with Integrated Syringe Label® (pre-filled syringes with integrated labeling for clinical efficiency), Intelligent Packaging Design (proprietary packaging solutions for safety and usability), and Robust Supply Chain (logistics services for global distribution). The company delivers more than 140 million doses annually across 65+ active ingredients in 45+ countries, positioning the injectable medicines portfolio as the central platform with specialized packaging and supply chain services as complementary capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Generic Injectable Medicines Portfolio Broad range of generic injectable medicines covering analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products used in hospitals, pharmacies, outpatient surgery centres, and palliative care settings.
  • Ready-to-Use Products with Integrated Syringe Label Pre-filled syringes and ready-to-administer injectable products featuring an integrated syringe label designed to improve preparation efficiency and reduce medication errors in clinical settings.
  • Intelligent Packaging Design Proprietary packaging solutions designed to enhance safety, usability, and efficiency in the handling and administration of injectable medicines.

Quantifiable outcome

  • Over 140 million doses delivered to customers in 2024
  • +2 more outcomes

Companies that use Hameln Pharma Ltd

Customer profile

Segments5 records

Ideal customer profiles3 records

Hameln Pharma Ltd technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Hameln Pharma Ltd partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Hameln Pharma Ltd competitors and assessment

Company assessment

Broad incumbents

  • Sun Pharmaceutical Industries: Indian-headquartered global generics manufacturer with sterile injectables in its portfolio. Less concentrated in injectables than Hameln, but competes for hospital tenders in overlapping markets.
  • Viatris: Global generics and specialty company formed from Mylan and Upjohn, with injectable products serving hospital and surgical markets. Overlaps with Hameln in hospital-channel generic injectables but operates with much greater therapeutic and geographic breadth.
  • Sandoz: Global generics leader and Novartis spin-off with a sizable sterile injectable franchise across antibiotics, oncology, and hospital injectables. Overlaps with Hameln in generic injectables for hospitals but operates at significantly larger scale and breadth.
  • Teva Pharmaceutical Industries: One of the world's largest generic drug manufacturers with a meaningful injectable portfolio serving hospitals. Competes with Hameln in tender-based generic injectable markets but is far broader in scope (oral solids, biosimilars, APIs).
  • Pfizer CentreOne (Hospira heritage): Pfizer's injectables business, built on the Hospira acquisition, supplies a broad hospital injectable portfolio including analgesics and anesthesia adjacents. Competes with Hameln in the same hospital channels but at much larger scale and broader therapeutic depth.

Direct peers

  • Aurobindo Pharma: Indian-headquartered generic pharmaceutical manufacturer with a growing sterile injectables business supplying regulated markets including Europe. Comparable to Hameln in targeting generic injectable tenders and hospital accounts.
  • Fresenius Kabi: German-headquartered global supplier of generic injectable medicines, IV drugs, and clinical nutrition to hospitals. Directly comparable to Hameln in therapeutic focus, customer base (hospitals), and reliance on tender-based generic injectable distribution.
  • B. Braun: German medical and pharmaceutical company with a major sterile injectable and infusion solutions business serving hospitals globally. Closely matches Hameln on geography of origin, injectable expertise, and hospital-channel distribution model.
  • Hikma Pharmaceuticals: Specialty generic injectable manufacturer with strong hospital channel presence across Europe, MENA, and the US. Comparable to Hameln in portfolio breadth (anesthetics, analgesics, critical care injectables) and contract/tender-driven sales.
  • Dr. Reddy's Laboratories: Indian generics company with a focused sterile injectables portfolio (anesthetics, oncology injectables) sold into European and emerging markets. Comparable to Hameln in therapeutic mix and regulatory-driven hospital sales.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Hameln Pharma Ltd social profiles

Digital presence

Hameln Pharma Ltd financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hameln Pharma Ltd leadership team

Management profile

Number of profiles

Hameln Pharma Ltd subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Hameln Pharma Ltd funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hameln Pharma Ltd M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hameln Pharma Ltd

What does Hameln Pharma Ltd do?

Hameln Pharma Ltd is a fourth-generation owner-managed pharmaceutical group that develops, licenses, manufactures, and markets generic injectable medicines, including analgesics, anesthetics, sedatives, antiemetics, antidotes, opioids, and critical care products. The company delivers more than 140 million doses per year across 65+ active ingredients to hospitals, pharmacies, outpatient surgery centres, medical practices, and palliative care centres in more than 45 countries through nine wholly owned subsidiary companies.

Is Hameln Pharma Ltd a public or private company?

Hameln Pharma Ltd is a private company. It is classified as family owned and is currently operating.

When was Hameln Pharma Ltd founded?

Hameln Pharma Ltd was founded in 1890. It employs 11 to 50 people.

Where is Hameln Pharma Ltd based?

Hameln Pharma Ltd is headquartered in Gloucester, United Kingdom, in the Europe region.

How does Hameln Pharma Ltd make money?

One revenue line is on record: generic Injectable Medicines Sales.

Who are Hameln Pharma Ltd's main competitors?

Broad incumbents on record are Sun Pharmaceutical Industries, Viatris, Sandoz, Teva Pharmaceutical Industries and Pfizer CentreOne (Hospira heritage). Direct peers are Aurobindo Pharma, Fresenius Kabi, B. Braun, Hikma Pharmaceuticals and Dr. Reddy's Laboratories.

Does Hameln Pharma Ltd have an API?

No public API is recorded for Hameln Pharma Ltd.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales